ISA Pharmaceuticals B.V.

The final installation of our series looking at industry leaders’ expectations for the year ahead focuses on sustainability and equity: in health care, in companies and across society as a whole. Tom

Evolution of clinical trials was a major theme among executives who at the end of 2021 shared their predictions for 2022. Remote, or decentralized, trials was a common talking point, as was the harnes

There has been progress in the development of therapeutic vaccines, notably in oncology, and advances in the production of cervical cancer treatments. Cervical cancer is a serious illness that affects

“Biomedical innovation is at its golden age, and scientific innovation will continue to be strong,” declared Søren Møller , managing partner at Novo Seeds , the life science start-up financing arm o